Summary
- Current Price
- As of today, DVA price is $183.69, down -0.04% on
- Current Price All-Time High
- DVA price is currently -25.78% below its historical high of $247.49 set on
- Market Cap
- DVA current market cap is $12B, up +22.67% over the past 365 days
- PE Ratio
- DVA current PE ratio is 15.49
- Revenue
- DVA current annual revenue is $13.64B, up +6.46% year-over-year
- Next Earnings
- The next earnings release for DVA is on
Profile
| Metric | Value |
|---|---|
| Full Name | DaVita Inc. |
| Ticker | NYSE: DVA |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Country | United States |
| IPO | |
| Indexes | |
| Website | davita.com |
| Employees | 76,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $183.69 | |
| Price, 1D Change | -0.04% | |
| Market Cap | $12B | |
| - | ||
| PE Ratio | 15.49 | |
| Beta | 0.03 | |
| Revenue | $13.64B | |
| Revenue, 1Y Change | +6.46% | |
| EPS | $9.51 | |
| EPS, 1Y Change | -11.34% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $9.51 | |
| EPS Estimate | $14.83 | N/A |
| EPS Est. Change | +55.92% | N/A |
| Revenue | $13.64B | |
| Revenue Estimate | $14.15B | N/A |
| Revenue Est. Change | +3.69% | N/A |
| Current Price | $183.69 | |
| Price Target | $224.00 | - |
| Price Tgt. Change | +21.94% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.73 | $10.73 | +10.28% | |
| $10.69 | $9.51 | -11.03% | |
| $14.83 | N/A | +55.92% | |
| $17.03 | N/A | +79.07% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.76B | $12.82B | +0.44% | |
| $13.51B | $13.64B | +0.95% | |
| $14.15B | N/A | +3.69% | |
| $14.61B | N/A | +7.11% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +41.85% | |
| Price, 3Y | +69.41% | |
| Market Cap, 1Y | +22.67% | |
| Market Cap, 3Y | +19.13% | |
| Revenue, 1Y | +6.46% | |
| Revenue, 3Y | +17.51% | |
| EPS, 1Y | -11.34% | |
| EPS, 3Y | +66.66% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $183.69 | |
| SMA 200 | $158.84 | |
| SMA 50 | $217.20 | |
| EMA 200 | $175.03 | |
| EMA 50 | $213.39 | |
| MACD | -$7.94 | |
| Beta | 0.03 | |
| ATR | $8.91 | |
| 14-Day RSI | 24.17 | |
| 10-Day Volatility | 88.51% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $13.64B | |
| EPS | $9.51 | |
| Gross Profit | $3.68B | |
| Gross Margin | 27.00% | |
| Operating Income | $2.01B | |
| Operating Margin | 14.74% | |
| Net Income | $1.05B | |
| Net Margin | 7.72% | |
| EBITDA | $2.73B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | -19.77 | |
| 1.29 | ||
| 1.24 | ||
| - | ||
| 8 | ||
| 1.57 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 15.49 | |
| 0.84 | ||
| -15.41 | ||
| 8.72 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | -$651.08M | |
| $782.05M | ||
| $18.11B | ||
| $4.06B | ||
| $16.95B | ||
| $3.14B | ||
| Total Debt | $13.07B | |
| $534.69M | ||
| $696.15M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $12.92B | ||
| $1.67B | ||
| $9.96B | ||
| $0.00 | ||
| $715.35M | ||
| $0.00 | ||
| $293.11M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $1.89B | ||
| -$671.62M | ||
| -$1.36B | ||
| Capex | $575.86M | |
| $1.31B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Truist Securities | → | |
| TD Cowen | → | |
| Barclays | → | |
| Truist Securities | → | |
| UBS | → | |
| Barclays | → | |
| TD Cowen | → | |
| Truist Securities | → | |
| Barclays | → | |
| UBS | → |
Analyst sentiment
Institutional ownership
Screeners with DVA
FAQ
- What is the ticker symbol for DaVita Inc.?
- The ticker symbol for DaVita Inc. is NYSE:DVA
- Does DaVita Inc. pay dividends?
- No, DaVita Inc. does not pay dividends
- What sector is DaVita Inc. in?
- DaVita Inc. is in the Healthcare sector
- What industry is DaVita Inc. in?
- DaVita Inc. is in the Medical Care Facilities industry
- What country is DaVita Inc. based in?
- DaVita Inc. is headquartered in United States
- When did DaVita Inc. go public?
- DaVita Inc. initial public offering (IPO) was on October 31, 1995
- Is DaVita Inc. in the S&P 500?
- Yes, DaVita Inc. is included in the S&P 500 index
- Is DaVita Inc. in the NASDAQ 100?
- No, DaVita Inc. is not included in the NASDAQ 100 index
- Is DaVita Inc. in the Dow Jones?
- No, DaVita Inc. is not included in the Dow Jones index
- When was DaVita Inc. last earnings report?
- DaVita Inc.'s most recent earnings report was on August 4, 2026
- When does DaVita Inc. report earnings?
- The next expected earnings date for DaVita Inc. is October 28, 2026
Data Sources & References
- DVA Official Website www.davita.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/927066/000092706626000004/0000927066-26-000004-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- DVA Profile on Yahoo Finance finance.yahoo.com/quote/DVA
- DVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dva
